Gilead Sciences (GILD) Financials
Gilead Sciences (GILD) Historical Financial Statements and Key Metrics for 1992 - 2020
Full Gilead Sciences financials for 1992 - 2020 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Gilead Sciences Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2020-Dec-31 | 7,421 | 6,023 (81.2 %) | 2,651 (35.7 %) | 1,517 (20.4 %) | 1,886 | 1.21 |
| 2020-Sep-30 | 6,577 | 5,436 (82.7 %) | 2,001 (12.5 %) | 360 (5.5 %) | 1,416 | 0.29 |
| 2020-Jun-30 | 5,143 | 4,079 (79.3 %) | -2,983 (-58.0 %) | -3,339 (-64.9 %) | -2,377 | -2.66 |
| 2020-Mar-31 | 5,548 | 4,579 (82.5 %) | 2,402 (43.3 %) | 1,551 (28.0 %) | 2,606 | 1.22 |
| 2019-Dec-31 | 5,879 | 4,196 (71.4 %) | 1,093 (18.6 %) | 2,696 (45.9 %) | 2,501 | 2.12 |
| 2019-Sep-30 | 5,604 | 4,569 (81.5 %) | -1,473 (-26.3 %) | -1,165 (-20.8 %) | -901 | -0.92 |
| 2019-Jun-30 | 5,685 | 4,685 (82.4 %) | 2,430 (42.7 %) | 1,880 (33.1 %) | 3,011 | 1.47 |
Full historical income statements for 1992 - 2020 is included in the
US Historical Financials dataset.
Gilead Sciences Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2020-Dec-31 | 68,407 | 50,205 | 31,402 | 18,202 | 7,408 |
| 2020-Sep-30 | 60,878 | 43,407 | 29,290 | 17,445 | 23,975 |
| 2020-Jun-30 | 55,934 | 37,907 | 24,102 | 18,027 | 18,914 |
| 2020-Mar-31 | 59,741 | 37,674 | 24,097 | 22,067 | 20,785 |
| 2019-Dec-31 | 61,627 | 39,102 | 24,593 | 22,525 | 24,352 |
| 2019-Sep-30 | 59,146 | 38,542 | 24,588 | 20,604 | 22,856 |
| 2019-Jun-30 | 63,210 | 40,594 | 26,083 | 22,616 | 27,183 |
Full historical balance sheet data for 1992 - 2020 is included in the
US Historical Financials dataset.
Gilead Sciences Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2020-Dec-31 | 1,916 | -14,615 | 770 | 2,385 |
| 2020-Sep-30 | 2,250 | 0 | 0 | 2,095 |
| 2020-Jun-30 | 2,566 | -5,023 | -874 | 2,423 |
| 2020-Mar-31 | 1,436 | -344 | -2,611 | 1,265 |
| 2019-Dec-31 | 2,580 | 431 | -896 | 2,377 |
| 2019-Sep-30 | 2,645 | -1,841 | -2,515 | 2,445 |
| 2019-Jun-30 | 2,342 | -6,163 | -1,857 | 2,157 |
Full historical cash flow data for 1992 - 2020 is included in the
US Historical Financials dataset.
Gilead Sciences Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2020-Dec-31 | 73,116 | 98,521 | 9.85 | 48.20 | 4.02 |
| 2020-Sep-30 | 79,303 | 105,298 | 12.06 | 220.29 | 4.55 |
| 2020-Jun-30 | 96,560 | 110,917 | 18.77 | -28.92 | 5.36 |
| 2020-Mar-31 | 94,108 | 106,155 | 16.96 | 60.68 | 4.26 |
| 2019-Dec-31 | 81,297 | 91,760 | 13.83 | 30.15 | 3.61 |
| 2019-Sep-30 | 78,127 | 90,743 | 13.94 | -67.06 | 3.79 |
| 2019-Jun-30 | 83,492 | 96,336 | 14.69 | 44.41 | 3.69 |
Full historical valuation and operating metrics for 1992 - 2020 are included in the
US Historical Financials dataset.